Should we treat patients with a target dose or a target LDL level? How often is it helpful to check lipid levels? For primary and secondary prevention, when should we think about using PCSK9 inhibitors, omega-3 fatty acids, niacin, or fibrates?
Just how common is primary aldosteronism anyway? Is an aldosterone-renin ratio the best screening test for primary aldosteronism, or is it something else? How often should we think about screening?